Swiss arbitrator can rule in Crimea investment case
Switzerland’s Federal Court has rejected two appeals by Russia contesting the competence of a Geneva-based arbitrator in a case brought by Ukrainian companies.
This content was published on
1 minute
SDA-ATS/jc
The Swiss arbitrator may now rule on claims by twelve Ukrainian companies whose assets were confiscated in Crimea.
One of them, which had a network of service stations in Crimea, is claiming $50 million (CHF49.4 million) for expropriation of its property following Russia’s annexation of Crimea in 2014. The claims of the other companies amount to a total of $47.4 million.
Moscow argued that the 1998 accord did not apply to investments which were not cross-border at the time they were made. However, the judges of Switzerland’s highest court dismissed this argument by a majority of four to one.
Russia’s legal costs amount to CHF115,000 for the first appeal and CHF110,000 for the second. Indemnities were also awarded to the Ukrainian companies.
Since the two sides could not reach agreement, the case was assigned under the rules of the 1998 agreement for arbitration by Swiss jurist Gabrielle Kaufmann-KohlerExternal link, who is based in Geneva.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Over 6,000 Swiss companies go bankrupt but start-ups see growth
This content was published on
Switzerland recorded a spike in bankruptcies last year, but there was also a rise in new start-ups. Trends varied significantly by region and sector.
Basel greenlights funding for Eurovision Village 2025
This content was published on
MCH Group Ltd. is set to receive CHF1 million ($1.1 million) for the Eurovision Village at the Eurovision Song Contest 2025 in Basel.
Geneva researchers discover potential for targeted cancer drug delivery
This content was published on
Researchers in Geneva have discovered how some bacteria inject dangerous enzymes into cells, potentially enabling targeted drug delivery to cancer cells.
Macron denies involvement in Nestlé Waters scandal
This content was published on
French President Emmanuel Macron denied any “agreement” or “collusion” with the Swiss company Nestlé over the bottled water scandal on Tuesday.
UBS has cut 10,000 jobs since Credit Suisse takeover in 2023
This content was published on
UBS Group has cut more than 10,000 roles since it bought Credit Suisse, marking a milestone in the lender’s efforts to integrate its former rival.
Swiss multinational SGS to move HQ from Geneva to Zug
This content was published on
The Swiss multinational SGS, the world’s leading testing, inspection and certification company, plans to move its headquarters from Geneva to canton Zug in central Switzerland.
Swiss army takes part in international tank competition
This content was published on
Around 20 Swiss army personnel and two Leopard 2 tanks are taking part in an international tank competition in Grafenwöhr, Germany, this week.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss visit by Russia’s State Duma speaker sparks controversy
This content was published on
The official visit to Switzerland by Vyacheslav Volodin, the speaker of the Russian parliament’s lower house, the State Duma, has sparked controversy.
This content was published on
Chairman Edwin Eichler will stand for re-election at next week’s annual general meeting, but no longer as a representative of Renova, the Swiss firm announced on Monday. Vladimir Polienko will stand down, leaving Marco Musetti as the only Renova-appointed representative on the board if elected. The move to reduce the Schmolz + Bickenbach board from…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.